PRWeb The Leader Press Release Distribution

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for November 15, 2008 Subscribe to this News Feed    
 

Biotrial, Full-Service CRO and European Leader in Drug Evaluation and Pharmacology Research, Appoints New Head to Manage its Growing Data Management Activity

Biotrial, a leading CRO for early phase clinical trials, today announced that Monique Duguépéroux-Klocke has joined the company as its new Head of Data Management.

Rennes, France (PRWEB) November 15, 2008 -- Since 1989 Biotrial has provided consistent and reliable clinical data management for in-house clinical trials, as well as complex global clinical studies. From CRF design, data entry, database design, data validation, statistics and consulting, to name a few, Biotrial's experience includes a wide range of therapeutic areas.

Monique Duguépéroux-Klocke brings over 15 years of experience in the field of clinical research. After leaving a well-known CRO (PAREXEL in Berlin) she worked for over 10 years at one of the top French pharmaceutical companies: Servier Laboratories, as head of the Data Management, Outsourcing Department.

"We are really excited about these new changes in Biotrial's Data Management department," said Isabelle Cimarosti, Director of Biometrics Department. "Monique Duguépéroux-Klocke's arrival attests to our growth and reinforces our position as a global service provider."

Her responsibilities at Biotrial include overseeing the department's activity and monitoring its constant growth with thorough training, recruitment and technical means. In the near future, one of her missions will be to answer client needs for data management in Phase III studies in addition to evolving Biotrial's EDC system. Ms. Duguépéroux-Klocke holds a Master's Degree in Chemistry, and has been a member of the Data Management Biomedical Association since 1998.
Jean-Marc Gandon, Biotrial CEO, commented: "Mrs Duguépéroux-Klocke is a valuable addition to our management team. Her vast experience and her extensive background will be a great asset to the company and to our clients. With over 130 projects handled last year, the biometrics activity is in constant growth. Our team of Database Programmers and Designers, Coding Specialists, Data Entry Operators, and Data Management Project Leaders are excited about this new arrival and see it as an opportunity to continue the development of this activity within the wide range of quality clinical services offered by Biotrial."
Philippe L'Hostis who was previously heading this department will now be heading the Biotrial ECG and Imaging Central Laboratory activities.
About Biotrial

Founded in 1989 by Jean-Marc Gandon, PharmD, (President & CEO), Biotrial (www.biotrial.com) is an independent and privately owned CRO.
With 150 beds and a staff of 250 in several subsidiaries in France and the UK, Biotrial runs over 80 studies per year, either in their own clinics in Paris and Rennes, or in cooperation with hospital specialists and general practitioners.
With a large range of services from Phase I studies, Clinical Trial Management Phase II-IV, Oncology, Data Management, Biostatistics, Central Labs (ECG, Imaging), Medical Writing, Non-Clinical Pharmacology, QA & advice in Regulatory Affairs, Biotrial can manage every step of your development process.

For further information please contact Anne Peron at +33 (0)2 99 599 191 or visit www.biotrial.com.

###

OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
Allison Kinnucan
Biotrial
33 (0)2 99 59 91 91
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.